703 related articles for article (PubMed ID: 18359613)
21. Interspecies dissemination of a novel class 1 integron carrying blaIMP-19 among Acinetobacter species in Japan.
Yamamoto M; Nagao M; Matsumura Y; Matsushima A; Ito Y; Takakura S; Ichiyama S
J Antimicrob Chemother; 2011 Nov; 66(11):2480-3. PubMed ID: 21862476
[TBL] [Abstract][Full Text] [Related]
22. Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil.
Carvalho KR; Carvalho-Assef AP; Peirano G; Santos LC; Pereira MJ; Asensi MD
Int J Antimicrob Agents; 2009 Jul; 34(1):25-8. PubMed ID: 19216059
[TBL] [Abstract][Full Text] [Related]
23. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58.
Héritier C; Dubouix A; Poirel L; Marty N; Nordmann P
J Antimicrob Chemother; 2005 Jan; 55(1):115-8. PubMed ID: 15590718
[TBL] [Abstract][Full Text] [Related]
24. Genetic diversity and clonal evolution of carbapenem-resistant Acinetobacter baumannii isolates from Portugal and the dissemination of ST118.
Manageiro V; Jones-Dias D; Ferreira E; Louro D; ; Caniça M
Int J Antimicrob Agents; 2012 Nov; 40(5):398-403. PubMed ID: 22890192
[TBL] [Abstract][Full Text] [Related]
25. An outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China.
Zong Z; Lü X; Valenzuela JK; Partridge SR; Iredell J
Int J Antimicrob Agents; 2008 Jan; 31(1):50-4. PubMed ID: 18077141
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of OXA-51-type class D beta-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres.
Vahaboglu H; Budak F; Kasap M; Gacar G; Torol S; Karadenizli A; Kolayli F; Eroglu C
J Antimicrob Chemother; 2006 Sep; 58(3):537-42. PubMed ID: 16816400
[TBL] [Abstract][Full Text] [Related]
27. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
Poirel L; Nordmann P
Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
[TBL] [Abstract][Full Text] [Related]
28. Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy.
Zarrilli R; Casillo R; Di Popolo A; Tripodi MF; Bagattini M; Cuccurullo S; Crivaro V; Ragone E; Mattei A; Galdieri N; Triassi M; Utili R
Clin Microbiol Infect; 2007 May; 13(5):481-9. PubMed ID: 17430339
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of OXA-143 and alteration of outer membrane proteins in carbapenem-resistant Acinetobacter spp. isolates in Brazil.
Mostachio AK; Levin AS; Rizek C; Rossi F; Zerbini J; Costa SF
Int J Antimicrob Agents; 2012 May; 39(5):396-401. PubMed ID: 22455794
[TBL] [Abstract][Full Text] [Related]
30. Carbapenem-resistant and OXA-23-producing Acinetobacter baumannii isolates in the United Arab Emirates.
Mugnier P; Poirel L; Pitout M; Nordmann P
Clin Microbiol Infect; 2008 Sep; 14(9):879-82. PubMed ID: 18844691
[TBL] [Abstract][Full Text] [Related]
31. Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China.
Fu Y; Zhou J; Zhou H; Yang Q; Wei Z; Yu Y; Li L
J Antimicrob Chemother; 2010 Apr; 65(4):644-50. PubMed ID: 20154023
[TBL] [Abstract][Full Text] [Related]
32. Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a teaching hospital in China.
Hu Q; Hu Z; Li J; Tian B; Xu H; Li J
J Basic Microbiol; 2011 Oct; 51(5):467-72. PubMed ID: 21656808
[TBL] [Abstract][Full Text] [Related]
33. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan.
Huang LY; Chen TL; Lu PL; Tsai CA; Cho WL; Chang FY; Fung CP; Siu LK
Clin Microbiol Infect; 2008 Nov; 14(11):1010-9. PubMed ID: 19040472
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore.
Lim TP; Tan TY; Lee W; Sasikala S; Tan TT; Hsu LY; Kwa AL
J Antibiot (Tokyo); 2009 Dec; 62(12):675-9. PubMed ID: 19876075
[TBL] [Abstract][Full Text] [Related]
35. Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran.
Peymani A; Higgins PG; Nahaei MR; Farajnia S; Seifert H
Int J Antimicrob Agents; 2012 Jun; 39(6):526-8. PubMed ID: 22521767
[TBL] [Abstract][Full Text] [Related]
36. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.
Mendes RE; Bell JM; Turnidge JD; Castanheira M; Jones RN
J Antimicrob Chemother; 2009 Jan; 63(1):55-9. PubMed ID: 18957398
[TBL] [Abstract][Full Text] [Related]
37. Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy.
Mezzatesta ML; D'Andrea MM; Migliavacca R; Giani T; Gona F; Nucleo E; Fugazza G; Pagani L; Rossolini GM; Stefani S
Clin Microbiol Infect; 2012 Feb; 18(2):160-6. PubMed ID: 21722261
[TBL] [Abstract][Full Text] [Related]
38. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
[TBL] [Abstract][Full Text] [Related]
39. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan.
Lee YT; Huang LY; Chiang DH; Chen CP; Chen TL; Wang FD; Fung CP; Siu LK; Cho WL
Int J Antimicrob Agents; 2009 Dec; 34(6):580-4. PubMed ID: 19733035
[TBL] [Abstract][Full Text] [Related]
40. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii.
Amudhan SM; Sekar U; Arunagiri K; Sekar B
Indian J Med Microbiol; 2011; 29(3):269-74. PubMed ID: 21860108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
